SOUTHFIELD, Mich. (March 31, 2024) – Lumigen
HyPerBlu, a novel chemiluminescent substrate now available from
Beckman Coulter, Inc., enables direct detection of hydrogen
peroxide. Combining a broad dynamic range and bright,
sustained chemiluminescence, the ready-to-use reagent offers
unmatched convenience for high-throughput screening
laboratories.
Reaction of the substrate with hydrogen peroxide rapidly
generates sustained high-intensity luminescence for maximum
sensitivity in solution assays. Direct detection increases
accuracy and simplifies data analysis. When coupled with
oxidases, the reagent also allows reliable, one-step, indirect
detection of oxidases or their substrates.
HyPerBlu is provided as a single solution and does not require
mixing. It is stable for one year when stored in an amber
bottle at 2-8 degrees C.
"Detection of hydrogen peroxide is an important and widely used
component of the drug discovery process," noted Ed Pagani, vice
president and general manager of molecular diagnostics, Beckman
Coulter, Inc. "HyPerBlu saves time and delivers accurate
results, qualities that should be highly desirable to researchers
in high-throughput screening laboratories."
About Beckman Coulter
Beckman Coulter, Inc., based in Orange County, California,
develops, manufactures and markets products that simplify, automate
and innovate complex biomedical tests. More than 200,000
Beckman Coulter systems operate in laboratories around the world,
supplying critical information for improving patient health and
reducing the cost of care. Recurring revenue, consisting of
supplies, test kits and operating-type lease payments, represents
approximately 78 percent of the company's 2008 annual revenue of
$3.1 billion. For more information, visit www.beckmancoulter.com.
SOURCE